Cargando…

The emergence of the cause of rare diseases and rare disease patients’ movement

Detalles Bibliográficos
Autor principal:	Huyard, Caroline
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Meeting Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3504599/ http://dx.doi.org/10.1186/1750-1172-7-S2-A32

Ejemplares similares

Rare thyroid diseases
por: Łącka, Katarzyna
Publicado: (2013)

Vaccination risks in children with rare diseases
por: Barberi, Ignazio, et al.
Publicado: (2015)

Professional clinical guidelines for rare diseases: methodology
por: Kremp, Odile, et al.
Publicado: (2012)

Developing a national plan for rare diseases in Germany through concerted action: the national action league for people with rare diseases
por: Héon-Klin, Véronique, et al.
Publicado: (2012)

A rare cause of a right atrial mass
por: Law, Ho-fon Royce, et al.
Publicado: (2015)

The second French plan for rare diseases 2011-2014
por: Garcia, Alain, et al.
Publicado: (2012)

Compassionate use programmes for rare diseases: proposals for actions
por: Houÿez, François, et al.
Publicado: (2012)

Approaches in rare diseases and pediatrics across international boundaries
por: Liebman, Michael
Publicado: (2012)

The political empowerment of rare disease patient advocates both at EU and national level
por: Andersen, Terkel
Publicado: (2012)

Gene therapy for rare diseases – the case for acute intermittent Porphyria
por: Grosios, Konstantina
Publicado: (2014)

Children with rare diseases, is it true that they have an enhanced anesthesiological risk?
por: Sammartino, Maria, et al.
Publicado: (2015)

EPIRARE survey on activities and needs of rare disease registries in the European Union
por: Taruscio, Domenica, et al.
Publicado: (2012)

State of the art of rare disease activities in Europe: a EUCERD perspective
por: Aymé, Ségolène
Publicado: (2012)

Scope of centres of expertise for rare diseases in European countries where they exist
por: Rodwell, Charlotte, et al.
Publicado: (2012)

The Italian project to increase health professionals’ training and awareness on rare diseases
por: Bellagambi, Simona
Publicado: (2012)

PW03-012 – Unmet need in Behçet's disease: remission is rare
por: Alibaz-Oner, F, et al.
Publicado: (2013)

Molecular dissection of human B-cell tolerance – insights from patients with rare genetic diseases
por: Morbach, Henner, et al.
Publicado: (2014)

Value and specificity of rare diseases business model-is the pursuit of this societal priority sustainable?
por: Dunoyer, M, et al.
Publicado: (2012)

PW02-016 - 41 cases of TRAPS, a rare autoinflammatory disease
por: Chastang, M-C, et al.
Publicado: (2013)

A new book “Rare Diseases: Integrative PPPM Approach as the Medicine of the Future”
por: Özgüç, Meral
Publicado: (2014)

Children with rare diseases: do they really have an increased risk of developing epilepsy?
por: Pantaleoni, Chiara, et al.
Publicado: (2015)

10th European Conference on Rare Diseases & Orphan Products (ECRD 2020)
Publicado: (2020)

State of the art of rare disease activities around the world: overview of the non-European landscape
por: Wong-Rieger, Durhane
Publicado: (2012)

What can we learn about joint degeneration from rare and orphan diseases?
por: Gallagher, JA
Publicado: (2015)

Singleton-Merten Syndrome: a rare autoimmune disorder caused by a specific IFIH1 mutation
por: Buers, I, et al.
Publicado: (2015)

From rationing to rationality: an n-of-one trial service for off-label medicines for rare (neuromuscular) diseases
por: Weinreich, Stephanie S, et al.
Publicado: (2012)

First German Academy for Further Medical Training on Rare Diseases (FAKSE, http://www.fakse.info)
por: Giehl, Julia, et al.
Publicado: (2012)

P01-041 – Patient management and rare FMF symptoms
por: Moradian, MM, et al.
Publicado: (2013)

Carcinoid and hypocoagulation state in geriatric patients: a rare case
por: Migliaccio, Carla, et al.
Publicado: (2009)

Training medical students on rare disorders
por: Byrne, Paula C
Publicado: (2012)

Increased COVID-19 related mortality rate for patients with rare diseases: a retrospective cohort study with data from Genomics England
por: Zhang, Huayu, et al.
Publicado: (2021)

Classification and coding of rare diseases: overview of where we stand, rationale, why it matters and what it can change
por: Robinson, Peter N
Publicado: (2012)

Meeting abstracts from the 11th edition of the European conference on Rare Diseases & Orphan Products (ECRD) 2022
Publicado: (2023)

Fighting for the cures of rare genetic diseases: worthy ideas and promising results demand for strategic research management and for integration of competences and efforts
por: Sofia, Francesca
Publicado: (2012)

8th European Conference on Rare Diseases & Orphan Products (ECRD 2016): Edinburgh, UK. 26-28 May 2016
por: Schlander, Michael, et al.
Publicado: (2016)

Proceedings of 2nd Annual Charles River World Congress: Lessons Learned from Rare Disease and Personalized Medicine Approaches
Publicado: (2018)

Rare family days: a family empowerment programme
por: Lind, Ane, et al.
Publicado: (2012)

Rare fatal complications of acute fatty liver of pregnancy
por: Rahman, TM, et al.
Publicado: (1999)

Rare giant malignant tumors of the chest - reconstructive challenge
por: Kurowski, K, et al.
Publicado: (2015)

Novel orphan medicines and abandoned pathways - the US Orphan Drug Act of 1983 and the impact on rare rheumatologic diseases and lysosomal storage disorders
por: Ries, Markus, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_tlp46c6pcqnr1jqa7snqbme1j3